560
Participants
Start Date
October 3, 2022
Primary Completion Date
January 19, 2024
Study Completion Date
January 19, 2024
Quadrivalent Influenza mRNA Vaccine MRT5407
"Pharmaceutical Form: Liquid frozen solution in a vial~Route of Administration: Intramuscular Injection"
Quadrivalent Recombinant Influenza Vaccine
"Pharmaceutical Form: Liquid frozen solution in a vial~Route of Administration: Intramuscular Injection"
Quadrivalent Influenza Standard Dose Vaccine
"Pharmaceutical Form: Liquid suspension for injection in pre-filled syringe~Route of Administration: Intramuscular Injection"
Quadrivalent Influenza High-Dose Vaccine
"Pharmaceutical Form: Liquid suspension for injection in pre-filled syringe~Route of Administration: Intramuscular Injection"
Coastal Carolina Research Center - N Charleston Site Number : 8400010, North Charleston
SIMEDHealth, LLC Site Number : 8400024, Gainesville
Indago Research and Health Center Site Number : 8400014, Hialeah
Cenexel Research Centers of America Site Number : 8400048, Hollywood
Dade Research Center Site Number : 8400011, Miami
Suncoast Research Group, LLC Site Number : 8400038, Miami
Florida International Research Center Site Number : 8400051, Miami
Palm Beach Research Center Site Number : 8400020, West Palm Beach
AMR Knoxville Site Number : 8400046, Knoxville
AMR Lexington Site Number : 8400054, Lexington
Brengle Family Medicine Site Number : 8400005, Indianapolis
DM Clinical Research Site Number : 8400032, Melrose Park
DM Clinical Research - Chicago Site Number : 8400028, River Forest
AMR Kansas City Site Number : 8400006, Kansas City
Velocity Clinical Research Site Number : 8400003, Omaha
DM Clinical Research - Sugar Land Site Number : 8400031, Sugar Land
Sun Research Institute Site Number : 8400030, San Antonio
Clinical Trials of Texas, Inc. Site Number : 8400026, San Antonio
Elligo Health Research Site Number : 8400056, Austin
Peninsula Research Associates Site Number : 8400025, Rolling Hills Estates
Optimal Research Site Number : 8400059, San Diego
California Research Foundation Site Number : 8400008, San Diego
Accel Clinical Research-Deland Clinical Research Unit Site Number : 8400052, DeLand
Investigational Site Number : 6300003, Barrio Sabana
Investigational Site Number : 6300002, San Juan
Sanofi Pasteur, a Sanofi Company
INDUSTRY